JMML


Also found in: Medical.
AcronymDefinition
JMMLJuvenile Myelomonocytic Leukemia
JMMLJuina Mining Mineracao Ltda. (Brazil)
References in periodicals archive ?
They then tested the cells with two drugs, each able to inhibit a separate protein known to be highly active in JMML.
Hastalarin primer tanilari Hastalarin Primer Tanilari n (%) ALL 29 86 AML 4 12 JMML 1 2 NHL 10 26 Santral Sinir Sistemi Tumorleri 9 24.
5] The morphological subtype of acute leukemia observed were, ALL LI, L2and L3, APML and JMML.
One of the few reliable indicators of JMML cells is their tendency to proliferate in response to very low levels of a growth-stimulating factor called GM-CSF; normal cells respond only at higher levels.
The course of JMML is also highly variable: very rare children spontaneously go into remission with minimal treatment, while fully half of JMML patients suffer from a highly aggressive form of the disease that fails to respond to bone marrow transplant.
Mignon Loh, MD, a pediatric cancer specialist at UCSF Benioff Children s Hospital San Francisco who helped diagnose and treat Evan, said JMML is particularly devastating for families because the treatment required to cure children a bone marrow transplant is so intense.
AFTER bone marrow transplant, the relapse rate for children with JMML may be up to 50%.
JMML) JMML holds an 86% working interest in the mining and mineral rights to approximately 1000 hectares (2,471 acres) of diamond bearing land in the District of Juina, Mato Grosso, Brazil -- the "Property 1000.
In the next two to three months, she will be undergoing several other procedures that would bring her safely to a bone marrow transplant, the only treatment option for JMML.
The Charlotte Wren Forget Me Not Fund was launched in July and has already raised more than pounds 38,800 to pay for research into JMML and to sponsor a room in Charlotte's name at Crawford House, which provides free accommodation for families.
Neuroendocrine establish maximum (UK) (USA) tumors tolerated dose Q3 2002 - Carcinoid (weekly dosing) - Start - CTX granted for Phase II UK Phase I study Q4 2002 (more frequent dosing) E21R - CMML - AML Phase II - Global - Start BresaGen - JMML study stopped JMML Ltd (EU orphan - CMML pilot develop- (Australia) status Phase II study ment designation) ongoing Q3 2002 - JMML development - CMML under discussion Phase II with regulators results and external Q4 2003 experts MG98 - Gastric - AML/MDS Phase I - Europe - Start MethylGene cancer dose and schedule European Inc.
Money from the Wish campaign will be added to the pounds 26,000 already raised by the Charlotte Wren Forget-Me-Not Fund to pay for research into JMML and to sponsor a room in Charlotte's name at Crawford House, which provides free accommodation for local families who have to travel to Newcastle to receive medical treatment for children with life-threatening illnesses.